SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Stryker Corporation (SYK) trades at a trailing P/E of 39.6, forward P/E of 23.0. Trailing earnings yield is 2.52%, forward earnings yield 4.34%. PEG 4.83. Graham Number is $105.79.
Criteria proven by this page:
- VALUE (32/100, Fail) — PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 4.83).
- Forward P/E 23.0 (down from trailing 39.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 4.83 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 2.52% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.34% as earnings recover.
- Analyst consensus target $428.67 (+23.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 74/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
32/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SYK
Valuation Multiples
P/E (TTM)39.6
Forward P/E23.0
PEG Ratio4.83
Forward PEG0.29
P/B Ratio5.74
P/S Ratio5.12
EV/EBITDA25.0
Per Share Data
EPS (TTM)$8.49
Forward EPS (Est.)$15.01
Book Value / Share$58.61
Revenue / Share$65.66
FCF / Share$11.20
Yields & Fair Value
Earnings Yield2.52%
Forward Earnings Yield4.34%
Dividend Yield1.02%
Graham Number$105.79
SharesGrow IV$411.27 (+18.9%)
Analyst Target$428.67 (+23.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
27.2 |
1.79 |
4.69 |
3.96 |
1.27% |
| 2017 |
56.8 |
-1.50 |
5.81 |
4.65 |
1.10% |
| 2018 |
16.5 |
0.07 |
5.00 |
4.31 |
1.20% |
| 2019 |
37.7 |
-0.91 |
6.13 |
5.28 |
0.99% |
| 2020 |
57.5 |
-2.45 |
7.03 |
6.41 |
0.94% |
| 2021 |
50.6 |
2.09 |
6.78 |
5.89 |
0.94% |
| 2022 |
39.2 |
2.21 |
5.56 |
5.01 |
1.14% |
| 2023 |
35.9 |
1.06 |
6.11 |
5.55 |
1.00% |
| 2024 |
45.8 |
-7.96 |
6.65 |
6.07 |
0.89% |
| 2025 |
41.4 |
5.16 |
5.99 |
5.35 |
0.96% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.35 |
$11.33B |
$1.65B |
14.5% |
| 2017 |
$2.68 |
$12.44B |
$1.02B |
8.2% |
| 2018 |
$9.34 |
$13.6B |
$3.55B |
26.1% |
| 2019 |
$5.48 |
$14.88B |
$2.08B |
14% |
| 2020 |
$4.20 |
$14.35B |
$1.6B |
11.1% |
| 2021 |
$5.22 |
$17.11B |
$1.99B |
11.7% |
| 2022 |
$6.17 |
$18.45B |
$2.36B |
12.8% |
| 2023 |
$8.25 |
$20.5B |
$3.17B |
15.4% |
| 2024 |
$7.76 |
$22.6B |
$2.99B |
13.2% |
| 2025 |
$8.40 |
$25.12B |
$3.25B |
12.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$15.01 |
$14.07 – $15.12 |
$27.34B |
$26.95B – $27.57B |
16 |
| 2027 |
$16.79 |
$15.58 – $17.27 |
$29.64B |
$29.17B – $30.13B |
15 |
| 2028 |
$18.73 |
$16.92 – $20.09 |
$32.17B |
$32.11B – $32.24B |
5 |
| 2029 |
$21.03 |
$20.54 – $21.38 |
$35.09B |
$34.46B – $35.55B |
1 |
| 2030 |
$22.82 |
$22.29 – $23.21 |
$37.93B |
$37.24B – $38.42B |
1 |
